ClinicalTrials.gg
RecruitingNCT06193343STOPUpdated Apr 29, 2026

Steps Towards Osteoarthritis Prevention

An interventional study of Adaptive Daily Step Promotion in Anterior Cruciate Ligament Injuries, sponsored by University of Georgia. Recruiting at 1 site in United States. Open to participants aged 16 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-04-29.

Sponsored by University of Georgia · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Sep 2024; still recruiting 2 years 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Not applicable
Ages
16 Years to 40 Years
Sex
All
01

Study summary

Optimal knee joint loading, which refers to the forces acting on the knee caused by daily activities such as daily steps, plays an essential role in maintaining knee articular cartilage health and reducing the risk of osteoarthritis (OA). After anterior cruciate ligament reconstruction (ACLR), individuals take fewer daily steps as compared to uninjured controls resulting in insufficient knee joint loading to joint tissues, but it is unclear how changes in daily steps impact knee joint cartilage health in OA development. Therefore, the overall single arm, longitudinal pre-test post-test study objective is to determine the mechanistic links between knee joint loading as measured by daily steps and comprehensive magnetic resonance imaging (MRI) measures of knee joint cartilage health post-ACLR. The central hypothesis is that individuals post-ACLR who take low daily steps will demonstrate deconditioned, less resilient cartilage characterized by poor tibiofemoral cartilage composition and greater cartilage strain.

Read the detailed description

Osteoarthritis (OA) is a leading cause of disability. Identifying modifiable mechanisms of poor knee joint health development for disease prevention strategies are critical to improving long-term health. Aberrant mechanical loading has been theorized as a primary risk factor for knee OA. Most studies primarily focus on mechanical mechanisms of excessive joint loading in OA development. However, recent evidence suggests that joint underloading may also play a role. The effects of low loading frequency assessed via daily steps in real world settings on knee joint health is an understudied parameter of aberrant mechanical loading in individuals at risk for OA. Individuals with anterior cruciate ligament (ACL) injury who undergo ACL reconstruction (ACLR) surgery are a representative population to assess the effects of low loading frequency on knee joint health because they are at elevated risk for posttraumatic OA development and demonstrate low daily steps compared to uninjured individuals. Therefore, the overall study objective is to determine the mechanistic links between joint loading frequency and comprehensive magnetic resonance imaging (MRI) measures of knee joint cartilage health in individuals post-ACLR. The central hypothesis is that individuals post-ACLR who take low daily steps will demonstrate deconditioned, less resilient cartilage characterized by poor tibiofemoral cartilage composition and greater cartilage strain which represent equally important, but independent measures of cartilage health. Furthermore, increasing daily steps using a 16-week daily step promotion paradigm in individuals post-ACLR who underload (\<8000 daily steps which is predictive of physical inactivity) will recondition cartilage by improving tibiofemoral cartilage composition and strain. The proposed study aims to determine: 1) associations between daily steps with tibiofemoral cartilage composition and strain in ACLR individuals (n=56) using an observational cross-sectional study design, and 2) the effects of increasing daily steps over 16-weeks on tibiofemoral cartilage composition and strain in ACLR individuals with low daily steps (n=28) using a single arm, longitudinal pre-test post-test study design. The proposed study is innovative because it builds on observational studies linking underloading with poor knee joint health and will be the first study to mechanistically determine how altering loading frequency (i.e., increasing daily steps) affects comprehensive in vivo measures of cartilage health in individuals at risk for OA. Successful completion of the proposed study will provide foundational evidence for the development of a future randomized controlled trial to determine the efficacy of an adaptive daily step promotion.

02

Conditions studied

  • Anterior Cruciate Ligament Injuries
03

In context

Anterior Cruciate Ligament Injuries

625 studies on the registry are indexed under Anterior Cruciate Ligament Injuries; 192 are open to participants now.

This study's planned enrollment of 56 is close to the median of 56 across 458 interventional studies indexed under Anterior Cruciate Ligament Injuries.

Browse Anterior Cruciate Ligament Injuries studies →

Lead sponsor

University of Georgia is the lead sponsor of 74 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Provision of signed and dated form
  • For children, signed and dated informed assent by child and parental permission form by parent/guardian to participate in the study
  • Underwent an anterior cruciate ligament reconstruction (ACLR) between 6-60 months prior to enrollment
  • Stated willingness to comply with all study procedures and lifestyle considerations and availability for the duration of the study
  • Completed all other formal physical therapy and therapeutic exercise regimens, and will not be engaging in any other formal therapy for their ACLR during the study
  • Physician clearance for unrestricted activity
  • Owning a smartphone
  • Demonstrate \< 8,000 steps per day during the screening phase of aim 2 as assessed using the Actigraph Link monitor

Exclusion criteria

Exclusion Criteria:

  • Underwent an ACLR revision surgery due to a previous anterior cruciate ligament (ACL) graft injury
  • A multiple ligament surgery was indicated with their ACL injury
  • A lower extremity fracture was suffered during the ACL injury
  • The participant has previously been diagnosed with any diseases that affect joints is present in either knee including knee osteoarthritis inflammatory arthritis
  • Pregnant or plans to become pregnant over next 4 months
  • (BMI) ≥ 36 kg/m2
  • Unable to speak English
  • Cochlear implant
  • Metal in body (metal fragments, shrapnel, permanent make-up, body piercings that cannot be removed)
  • Claustrophobia
  • History of seizures
  • Pacemaker
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
56 participants (estimated)

Study arms

  • Experimental
    Interventional Group

    Participants who meet study criteria and are enrolled in adaptive daily step promotion intervention

    Behavioral: Adaptive Daily Step Promotion

Interventions

  • BehavioralAdaptive Daily Step Promotion

    Participants will wear a Fitbit monitor on their non-dominant wrist during a 10 to 14 day "run-in" screening to capture daily steps reported by the Fitbit but no daily step goals will be sent to the participant. The Fitbit monitor will be worn during all waking hours except water activities, and compliance will be considered as a day with ≥1,000 steps. Next, participants will undergo a 16-week intervention wearing the Fitbit monitor on their wrist and receive a text message each morning with a personalized, adaptive daily step count goal and a link used to confirm receipt of the goal. The preceding 10 days of step data will be rank ordered and the 60th percentile step count will be set as the goal for the next day. Goals will not exceed 10,000 daily steps.

06

What researchers measure

Primary outcomes

  1. T2 relaxation times in the medial femoral condyle

    MRI marker of T2 relaxation times of medial femoral articular cartilage (i.e collagen organization) at pre-intervention (baseline)

    Time frame: pre-intervention (baseline)

  2. T2 relaxation times in the lateral femoral condyle

    MRI marker of T2 relaxation times of lateral femoral articular cartilage (i.e collagen organization) at pre-intervention (baseline)

    Time frame: pre-intervention (baseline)

  3. T2 relaxation times in the medial tibial condyle

    MRI marker of T2 relaxation times of medial tibial articular cartilage (i.e collagen organization) at pre-intervention (baseline)

    Time frame: pre-intervention (baseline)

  4. T2 relaxation times in the lateral tibial condyle

    MRI marker of T2 relaxation times of lateral tibial articular cartilage (i.e collagen organization) at pre-intervention (baseline)

    Time frame: pre-intervention (baseline)

  5. Change in T2 relaxation times in the medial femoral condyle

    Change in MRI marker of T2 relaxation times of medial femoral articular cartilage (i.e collagen organization) from pre-intervention to post-intervention

    Time frame: pre-intervention (baseline), post-intervention (~18 weeks)

  6. Change in T2 relaxation times in the lateral femoral condyle

    Change in MRI marker of T2 relaxation times of lateral femoral articular cartilage (i.e collagen organization) from pre-intervention to post-intervention

    Time frame: post-intervention (~18 weeks)

  7. Change in T2 relaxation times in the medial tibial condyle

    Change in MRI marker of T2 relaxation times of medial tibial articular cartilage (i.e collagen organization) from pre-intervention to post-intervention

    Time frame: pre-intervention (baseline), post-intervention (~18 weeks)

  8. Change T2 relaxation times in the lateral tibial condyle

    Change in MRI marker of T2 relaxation times of lateral tibial articular cartilage (i.e collagen organization) from pre-intervention to post-intervention

    Time frame: pre-intervention (baseline), post-intervention (~18 weeks)

  9. Average cartilage strain in the medial femoral condyle

    MRI marker of cartilage strain (i.e., acute change in cartilage thickness/resting cartilage thickness) of medial femoral articular cartilage at pre-intervention (baseline)

    Time frame: pre-intervention (baseline)

  10. Average cartilage strain in the lateral femoral condyle

    MRI marker of cartilage strain (i.e., acute change in cartilage thickness/resting cartilage thickness) of lateral femoral articular cartilage at pre-intervention (baseline)

    Time frame: pre-intervention (baseline)

  11. Average cartilage strain in the medial tibial condyle

    MRI marker of cartilage strain (i.e., acute change in cartilage thickness/resting cartilage thickness) of medial tibial articular cartilage at pre-intervention (baseline)

    Time frame: pre-intervention (baseline)

  12. Average cartilage strain in the lateral tibial condyle

    MRI marker of cartilage strain (i.e., acute change in cartilage thickness/resting cartilage thickness) of lateral tibial articular cartilage at pre-intervention (baseline)

    Time frame: pre-intervention (baseline)

  13. Change in average cartilage strain in the medial femoral condyle

    Change in MRI marker of cartilage strain (i.e., acute change in cartilage thickness/resting cartilage thickness) of medial femoral articular cartilage from pre-intervention to post-intervention

    Time frame: pre-intervention (baseline), post-intervention (~18 weeks)

  14. Change in average cartilage strain in the lateral femoral condyle

    Change in MRI marker of cartilage strain (i.e., acute change in cartilage thickness/resting cartilage thickness) of lateral femoral articular cartilage from pre-intervention to post-intervention

    Time frame: pre-intervention (baseline), post-intervention (~18 weeks)

  15. Change in average cartilage strain in the medial tibial condyle

    Change in MRI marker of cartilage strain (i.e., acute change in cartilage thickness/resting cartilage thickness) of medial tibial articular cartilage from pre-intervention to post-intervention

    Time frame: pre-intervention (baseline), post-intervention (~18 weeks)

  16. Change in average cartilage strain in the lateral tibial condyle

    Change in MRI marker of cartilage strain (i.e., acute change in cartilage thickness/resting cartilage thickness) of lateral tibial articular cartilage from pre-intervention to post-intervention

    Time frame: pre-intervention (baseline), post-intervention (~18 weeks)

  17. Daily steps

    Average steps per day over 7 day physical activity monitor wear at pre-intervention (baseline)

    Time frame: Pre-intervention (baseline)

Other outcomes

  1. Change in daily steps

    Change in average steps per day over 7 day physical activity monitor wear from pre-intervention to post-intervention

    Time frame: Pre-intervention (baseline), post-intervention (~18 weeks)

  2. Change in Knee Injury and Osteoarthritis Outcome Score Quality of Life subscale

    Change in Knee injury Osteoarthritis Outcome Score (KOOS) Quality of Life subscale to measure knee-related quality of life from pre-intervention to post-intervention. A higher score indicates better knee-related quality of life. Min = 0 and Max = 100

    Time frame: Pre-intervention (baseline), post-intervention (~18 weeks)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Upon completion of the of the proposed projects, the overall data set will include outcome measures including: Participant demographics Knee injury history ACLR surgical procedure data Patient reported outcomes of self-reported knee function, physical activity, and psychological recovery Daily steps throughout the intervention using a Fitbit Daily steps before and after the intervention using a research grade tri-axial accelerometer Habitual gait speed Gait biomechanics at habitual gait speed Magnetic resonance imaging (i.e., T1ρ, T2, and Dess)) of the tibiofemoral and patellofemoral joint All of the information will be linked together, but deidentified. The data will be available to those who submit a formal written request to the PI and commit to only using the data for researcher purposes unplanned by the investigators. The data cannot be used to recruit or contact participants and must be destroyed or returned following the data analysis.

Supporting information: Study protocol, Informed consent form

Time frame: Data will be available for 10 years once all formal data collection, processing, and primary analysis is complete.

Access criteria: The data will be available to those who submit a formal written request to the PI and commit to only using the data for researcher purposes unplanned by the investigators.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06193343
Lead sponsor
University of Georgia
Responsible party
Sponsor
First posted
Jan 5, 2024
Start date
Sep 23, 2024
Primary completion
Jan 30, 2028 (estimated)
Completion
Jan 30, 2028 (estimated)
Last update
Apr 29, 2026

Study contacts

Caroline Lisee, PhD
Contact
caroline.lisee@uga.edu
706-542-7137
Caroline Lisee, PhD
principal investigator · University of Georgia

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion